相关实验视频

Updated: Jun 20, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

开发聚焦超声辅助纳米复合物用于RNA输送

Sanjeev Ranjan^1,2, Stef Bosch¹, Hannamari Lukkari^1,3

¹Institute of Biomedicine, University of Eastern Finland, 70210 Kuopio, Finland.

Nanomaterials (Basel, Switzerland)

|July 13, 2024

概括

适应性聚焦超声波 (AFU) 提供了一种新的非侵入性方法,用于将RNA疗法加载到纳米脂质体中,从而创建稳定的纳米复合体. 这种技术增强了RNA的保护,并实现了高基因沉默效率,克服了当前药物输送系统的局限性.

科学领域:

生物技术是生物技术.
纳米技术纳米技术
药物运输药物运输药物运输

背景情况:

包括小干扰RNA (siRNA) 在内的RNA疗法在治疗慢性和罕见疾病方面表现有前途.
目前用于RNA治疗的基于脂质的输送系统在临床应用中面临挑战,原因是配方和制备的复杂性.
优化纳米脂质体的设计和制备对于有效的RNA药物输送至关重要.

研究的目的:

引入适应性聚焦超声波 (AFU) 作为RNA疗法的新型,非侵入性药物加载技术.
在纳米脂质体内封装小RNA分子,形成稳定的纳米复合体,增强RNA保护.
评估AFU制备的纳米复合体的效率和特性,用于潜在的治疗应用.

主要方法:

适应性聚焦超声波 (AFU) 用于小干扰RNA (siRNA) 的非侵入性异热封装到纳米脂质体中.
该过程是在无菌条件下进行的,需要最小的样品体积 (300μL) 和短时间的处理时间 (10分钟).
量化聚合酶连锁反应 (qPCR),冷电子显微镜 (cryo-EM) 和原子力显微镜 (AFM) 用于评估基因沉默功效和纳米组特征.

主要成果:

AFU成功地生产了纳米复合物与封装的siRNA,保护RNA免受降解.
在体外实验中,在哺乳动物细胞系中使用沉默器CD44siRNA,证明了高基因沉默效率 (>80%).
冷电磁和AFM揭示了AFU形成的精确定义的纳米粒子 (100-200nm),与未经处理的样本中的集群复合物不同.

结论:

适应性聚焦超声波 (AFU) 是一种有希望的,快速的,无菌的,无溶剂的方法来处理和加载脂质体.
基于AFU的纳米复合体在RNA治疗中提供了潜在的进步,提高了稳定性和有效性.
这种技术解决了RNA药物输送当前的局限性,为改进的治疗策略铺平了道路.

关键词:

封装效率封装效率封装效率聚焦式超声波的使用脂质纳米颗粒的使用方法纳米复合体是一种纳米复合体.脂二层碎片的部分 siRNA的传递方式

更多相关视频

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Published on: April 16, 2019

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

相关概念视频

RNA Interference

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...